{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:18:47Z","timestamp":1785802727978,"version":"3.56.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,16]]},"DOI":"10.7759\/cureus.88122","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T03:48:08Z","timestamp":1752724088000},"source":"Crossref","is-referenced-by-count":5,"title":["Prevalence and Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus (hVISA) Among Clinical Isolates: A Comparative Evaluation of Screening Methods"],"prefix":"10.7759","author":[{"given":"Aditi","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipika","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivneet","family":"Kour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parakriti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipanshu","family":"Vasesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fux007","article-title":"Antibiotic resistance in Staphylococcus aureus. Current status and future prospects","volume":"41","author":"Foster TJ","year":"2017","unstructured":"Foster TJ. Antibiotic resistance in Staphylococcus aureus. Current status and future prospects. FEMS Microbiol Rev. 2017, 41:430-49. 10.1093\/femsre\/fux007","journal-title":"FEMS Microbiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.11.3970-3975.2002","article-title":"mecA gene is widely disseminated in Staphylococcus aureus population","volume":"40","author":"Wielders CL","year":"2002","unstructured":"Wielders CL, Fluit AC, Brisse S, Verhoef J, Schmitz FJ. mecA gene is widely disseminated in Staphylococcus aureus population. J Clin Microbiol. 2002, 40:3970-5. 10.1128\/JCM.40.11.3970-3975.2002","journal-title":"J Clin Microbiol"},{"key":"ref3","article-title":"Brief history of Staphylococcus aureus: a focus on antibiotic resistance","volume":"5","author":"Khan MF","year":"2017","unstructured":"Khan MF. Brief history of Staphylococcus aureus: a focus on antibiotic resistance. EC Microbiol. 2017, 5:36-9.","journal-title":"EC Microbiol"},{"key":"ref4","article-title":"Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs","author":"Grayson ML","year":"2017","unstructured":"Grayson ML, Cosgrove S, Crowe SM, et al.. Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs. CRC Press, Boca Raton, FL; 2017."},{"key":"ref5","article-title":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Document M100. Clinical and Laboratory Standards Institute","author":"Clinical and Laboratory Standards Institute","year":"2021","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Document M100. Clinical and Laboratory Standards Institute, Wayne, PA; 2021. https:\/\/www.treata.academy\/wp-content\/uploads\/2021\/03\/CLSI-31-2021.pdf."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01128-10","article-title":"Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method","volume":"49","author":"Satola SW","year":"2011","unstructured":"Satola SW, Farley MM, Anderson KF, Patel JB. Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J Clin Microbiol. 2011, 49:177-83. 10.1128\/JCM.01128-10","journal-title":"J Clin Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.07.003","article-title":"WHO publishes updated list of bacterial priority pathogens","volume":"5","author":"Jesudason T","year":"2024","unstructured":"Jesudason T. WHO publishes updated list of bacterial priority pathogens. Lancet Microbe. 2024, 5:100940. 10.1016\/j.lanmic.2024.07.003","journal-title":"Lancet Microbe"},{"key":"ref8","article-title":"Prevalence and antimicrobial susceptibility pattern of Staphylococcus aureus isolates at a tertiary care hospital in Chandigarh","volume":"10","author":"Gupta V","year":"2020","unstructured":"Gupta V, Garg R, Goel A, Chander J. Prevalence and antimicrobial susceptibility pattern of Staphylococcus aureus isolates at a tertiary care hospital in Chandigarh. J Infect Public Health. 2020, 10:20.","journal-title":"J Infect Public Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/9781555817381","article-title":"Manual of Clinical Microbiology","author":"Jorgensen JH","year":"2015","unstructured":"Jorgensen JH. Manual of Clinical Microbiology. ASM Press, Washington, DC; 2015. 10.1128\/9781555817381"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10020197","article-title":"Prevalence and characterization of methicillin-resistant Staphylococcus aureus from community- and hospital-associated infections: a tertiary care center study","volume":"10","author":"Preeja PP","year":"2021","unstructured":"Preeja PP, Kumar SH, Shetty V. Prevalence and characterization of methicillin-resistant Staphylococcus aureus from community- and hospital-associated infections: a tertiary care center study. Antibiotics (Basel). 2021, 10:10.3390\/antibiotics10020197","journal-title":"Antibiotics (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.9734\/jpri\/2021\/v33i59A34266","article-title":"Prevalence of MRSA and antimicrobial susceptibility Staphylococcus aureus in clinical samples in National Capital Region, India","volume":"33","author":"Kumar P","year":"2021","unstructured":"Kumar P, Gupta G, Gupta GK, Mishra V, Gupta G. Prevalence of MRSA and antimicrobial susceptibility Staphylococcus aureus in clinical samples in National Capital Region, India. J Pharm Res Int. 2021, 33:15. 10.9734\/jpri\/2021\/v33i59A34266","journal-title":"J Pharm Res Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2021\/48115.14622","article-title":"Prevalence and susceptibility profiles of methicillin-sensitive Staphylococcus aureus from community and hospital-associated infections","volume":"10","author":"Preeja P","year":"2021","unstructured":"Preeja P, Kumar S, Shetty VA. Prevalence and susceptibility profiles of methicillin-sensitive Staphylococcus aureus from community and hospital-associated infections. J Clin Diagn Res. 2021, 10:14622. 10.7860\/JCDR\/2021\/48115.14622","journal-title":"J Clin Diagn Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/248951","article-title":"Prevalence and antibiotic susceptibility of community-associated methicillin-resistant Staphylococcus aureus in a rural area of India: Is MRSA replacing methicillin-susceptible Staphylococcus aureus in the community?","volume":"2012","author":"Alvarez-Uria G","year":"2012","unstructured":"Alvarez-Uria G, Reddy R. Prevalence and antibiotic susceptibility of community-associated methicillin-resistant Staphylococcus aureus in a rural area of India: Is MRSA replacing methicillin-susceptible Staphylococcus aureus in the community?. ISRN Dermatol. 2012, 2012:248951. 10.5402\/2012\/248951","journal-title":"ISRN Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2019-0122","article-title":"Antibiotic resistance pattern of Staphylococcus aureus with reference to MRSA isolates from pediatric patients","volume":"6","author":"Gurung RR","year":"2020","unstructured":"Gurung RR, Maharjan P, Chhetri GG. Antibiotic resistance pattern of Staphylococcus aureus with reference to MRSA isolates from pediatric patients. Future Sci OA. 2020, 6:FSO464. 10.2144\/fsoa-2019-0122","journal-title":"Future Sci OA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2016.01.048","article-title":"Back to the future: penicillin-susceptible Staphylococcus aureus","volume":"129","author":"Cheng MP","year":"2016","unstructured":"Cheng MP, Ren\u00e9 P, Cheng AP, Lee TC. Back to the future: penicillin-susceptible Staphylococcus aureus. Am J Med. 2016, 129:1331-3. 10.1016\/j.amjmed.2016.01.048","journal-title":"Am J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2022.22","article-title":"Prevalence of methicillin-resistant Staphylococcus aureus in India: a systematic review and meta-analysis","volume":"37","author":"Patil SS","year":"2022","unstructured":"Patil SS, Suresh KP, Shinduja R, et al.. Prevalence of methicillin-resistant Staphylococcus aureus in India: a systematic review and meta-analysis. Oman Med J. 2022, 37:e440. 10.5001\/omj.2022.22","journal-title":"Oman Med J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00609-17","article-title":"Five-year summary of in vitro activity and resistance mechanisms of linezolid against clinically important gram-positive cocci in the United States from the LEADER Surveillance Program (2011 to 2015)","volume":"61","author":"Pfaller MA","year":"2017","unstructured":"Pfaller MA, Mendes RE, Streit JM, Hogan PA, Flamm RK. Five-year summary of in vitro activity and resistance mechanisms of linezolid against clinically important gram-positive cocci in the United States from the LEADER Surveillance Program (2011 to 2015). Antimicrob Agents Chemother. 2017, 61:10.1128\/AAC.00609-17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10070755","article-title":"Pharmacokinetic\/pharmacodynamic analysis of tedizolid phosphate compared to linezolid for the treatment of infections caused by gram-positive bacteria","volume":"10","author":"Rodr\u00edguez-Gasc\u00f3n A","year":"2021","unstructured":"Rodr\u00edguez-Gasc\u00f3n A, Aguirre-Qui\u00f1onero A, Aspiazu MA, Canut-Blasco A. Pharmacokinetic\/pharmacodynamic analysis of tedizolid phosphate compared to linezolid for the treatment of infections caused by gram-positive bacteria. Antibiotics (Basel). 2021, 10:10.3390\/antibiotics10070755","journal-title":"Antibiotics (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2017.07.001","article-title":"In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016","volume":"89","author":"Karlowsky JA","year":"2017","unstructured":"Karlowsky JA, Hackel MA, Bouchillon SK, Alder J, Sahm DF. In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016. Diagn Microbiol Infect Dis. 2017, 89:151-7. 10.1016\/j.diagmicrobio.2017.07.001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.14260\/jemds\/2017\/1272","article-title":"Prevalence and antibiotic sensitivity pattern of Staphylococcus aureus from all clinical samples with emphasis on MRSA in a tertiary care hospital","volume":"6","author":"Heyar AK","year":"2017","unstructured":"Heyar AK, Gill AK, Mahajan A, et al.. Prevalence and antibiotic sensitivity pattern of Staphylococcus aureus from all clinical samples with emphasis on MRSA in a tertiary care hospital. J Evol Med Dent Sci. 2017, 6:5857-60. 10.14260\/jemds\/2017\/1272","journal-title":"J Evol Med Dent Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2016.05.010","article-title":"Molecular characterization of antimicrobial resistance genes against Staphylococcus aureus isolates from Trinidad and Tobago","volume":"10","author":"Akpaka PE","year":"2017","unstructured":"Akpaka PE, Roberts R, Monecke S. Molecular characterization of antimicrobial resistance genes against Staphylococcus aureus isolates from Trinidad and Tobago. J Infect Public Health. 2017, 10:316-23. 10.1016\/j.jiph.2016.05.010","journal-title":"J Infect Public Health"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S340623","article-title":"In vitro activity of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant Staphylococcus aureus isolates collected from Chinese hospitals in 2018-2020","volume":"14","author":"Xu Y","year":"2021","unstructured":"Xu Y, Wang B, Zhao H, et al.. In vitro activity of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant Staphylococcus aureus isolates collected from Chinese hospitals in 2018-2020. Infect Drug Resist. 2021, 14:5449-56. 10.2147\/IDR.S340623","journal-title":"Infect Drug Resist"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69058-z","article-title":"Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis","volume":"10","author":"Shariati A","year":"2020","unstructured":"Shariati A, Dadashi M, Moghadam MT, van Belkum A, Yaslianifard S, Darban-Sarokhalil D. Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis. Sci Rep. 2020, 10:12689. 10.1038\/s41598-020-69058-z","journal-title":"Sci Rep"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.18502\/jmb.v13i1.18039","article-title":"Ardra M, Valsan C. Vancomycin minimum inhibitory concentration trend in methicillin-resistant Staphylococcus aureus from a tertiary care hospital in Central Kerala, India","volume":"13","year":"2025","unstructured":"Ardra M, Valsan C. Vancomycin minimum inhibitory concentration trend in methicillin-resistant Staphylococcus aureus from a tertiary care hospital in Central Kerala, India. J Med Bacteriol. 2025, 13.1-8. 10.18502\/jmb.v13i1.18039","journal-title":"J Med Bacteriol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2015.07.003","article-title":"Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: a multicenter surveillance study, 2012-2013","volume":"49","author":"Huang SH","year":"2016","unstructured":"Huang SH, Chen YC, Chuang YC, et al.. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: a multicenter surveillance study, 2012-2013. J Microbiol Immunol Infect. 2016, 49:701-7. 10.1016\/j.jmii.2015.07.003","journal-title":"J Microbiol Immunol Infect"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01435-10","article-title":"Detection of intermediately vancomycin-susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and Agar screening methods","volume":"49","author":"Riederer K","year":"2011","unstructured":"Riederer K, Shemes S, Chase P, Musta A, Mar A, Khatib R. Detection of intermediately vancomycin-susceptible and heterogeneous Staphylococcus aureus isolates: comparison of Etest and Agar screening methods. J Clin Microbiol. 2011, 49:2147-50. 10.1128\/JCM.01435-10","journal-title":"J Clin Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2015.0004","article-title":"Increasing trend of heterogeneous vancomycin-intermediate Staphylococcus aureus in a tertiary care center of Northern India","volume":"21","author":"Singh A","year":"2015","unstructured":"Singh A, Prasad KN, Misra R, et al.. Increasing trend of heterogeneous vancomycin-intermediate Staphylococcus aureus in a tertiary care center of Northern India. Microb Drug Resist. 2015, 21:545-50. 10.1089\/mdr.2015.0004","journal-title":"Microb Drug Resist"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/347427-prevalence-and-detection-of-heteroresistant-vancomycin-intermediate-staphylococcus-aureus-hvisa-among-clinical-isolates-a-comparative-evaluation-of-screening-methods","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T03:48:09Z","timestamp":1752724089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/347427-prevalence-and-detection-of-heteroresistant-vancomycin-intermediate-staphylococcus-aureus-hvisa-among-clinical-isolates-a-comparative-evaluation-of-screening-methods"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.88122","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,16]]}}}